Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
01/2007
01/25/2007US20070021447 2-Imino-4-(thio)oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors
01/25/2007US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
01/25/2007US20070021437 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma
01/25/2007US20070021428 2-Substituted phenyl-1,3-dihydropyrazolo(4,3-c)cinnolines, e.g., N-[3-(tert-butyl-methyl-amino)-butyl]-4-(6-fluoro-3-oxo-1,3-dihydro-pyrazolo[4,3-c]cinnolin-2-yl)-benzamide, are CD80 antagonists capable of inhibiting the interactions between CD80 and CD28, used for treating autoimmune diseases
01/25/2007US20070021427 Novel tricyclic derivatives and their use
01/25/2007US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
01/25/2007US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain
01/25/2007US20070021377 Pharmaceutical composition comprising a macrolide immunomodulator
01/25/2007US20070021354 Viricides; immunomoderator; mixture with other Aids drugs
01/25/2007US20070021329 Treatment of hypersensitivity conditions
01/25/2007US20070021321 determining whether catechin or an antibody has the same pharmacological effect as that of epigallocatechin gallate, on inhibiting cell proliferation, angiogenesis or cancer cell metastasis, as a neuroprotectant, a viricide, an antiallergen and as a antiarteriosclerotic agent
01/25/2007US20070020730 Method for overexpression of zwitterionic polysaccharides
01/25/2007US20070020673 Model of autoimmune disease and methods for identifying agents against autoimmune disease
01/25/2007US20070020296 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant
01/25/2007US20070020290 Natural antibodieactive against HIV virus
01/25/2007US20070020285 prophylactic and therapeutic vaccination directed against the hepatitis C virus
01/25/2007US20070020270 Human serpin polypeptides
01/25/2007US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis
01/25/2007US20070020262 Uses of mammalian cytokine: related reagents
01/25/2007US20070020260 Glycoprotein compositions
01/25/2007US20070017508 Methods for treating jaw pain
01/25/2007DE102005033809A1 Composition, useful for activating growth hormones and strengthening the immune system, comprises amino acids and isotonic saline
01/25/2007CA2854576A1 Human anti-b7rp1 neutralizing antibodies
01/25/2007CA2615980A1 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation
01/25/2007CA2615738A1 Bifunctional protein anchors
01/25/2007CA2615650A1 Novel piperidine derivatives
01/25/2007CA2614972A1 Human anti-b7rp1 neutralizing antibodies
01/25/2007CA2613778A1 Obtention of food- or auto-antigen specific tr1 cells from a leukocyte or pbmc population
01/25/2007CA2609929A1 Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders
01/24/2007EP1746159A2 Immunostimulatory nucleic acid molecules
01/24/2007EP1746103A1 Bifunctional protein anchors
01/24/2007EP1746095A1 Indanol derivative
01/24/2007EP1746093A1 Process for preparing substituted pyrimidines
01/24/2007EP1746086A1 Cyanopyrrolidine derivatives
01/24/2007EP1745800A1 Novel blt2-mediated disease, and blt2 binding agent and compound
01/24/2007EP1745798A2 Hcv vaccine compositions
01/24/2007EP1745780A1 Medicinal preparation
01/24/2007EP1745071A2 Msh-agonist tripeptide conjugates
01/24/2007EP1744775A1 Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency
01/24/2007EP1507531B1 Stable pharmaceutical compositions of desloratadine
01/24/2007EP1453492B1 Use of quinazolines to treat t-cell mediated diseases
01/24/2007EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist
01/24/2007EP1374901B1 Graft rejection suppressors
01/24/2007EP1363900B1 Isoindole-imide compounds, compositions and uses thereof
01/24/2007EP1341537B1 Pharmaceutically active isoindoline derivatives
01/24/2007EP1309591B1 Substituted pyrazoles
01/24/2007EP1181363B1 Recombinant human mannan-binding lectin
01/24/2007EP1180028B1 Il-8 receptor antagonists
01/24/2007EP1174151B1 Therapeutic treatment of eosinophilia using chymase inhibitors as the active ingredient
01/24/2007EP1126823B1 A process for the preparation of sterile therapeutically acceptable beclomethasone dipropionate
01/24/2007EP1123414B1 Antisense modulation of integrin alpha 4 expression
01/24/2007EP1032674B1 (chlamydia pneumoniae) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
01/24/2007EP1024812B1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
01/24/2007EP0973799B1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
01/24/2007EP0970213B1 Death domain containing receptor 5
01/24/2007EP0968206B8 N-heterocyclic derivatives as nos inhibitors
01/24/2007EP0811073B1 Use of immune modulators for making medicaments ot inhibit immune responses against co-administered recombinant viruses
01/24/2007EP0760000B1 Alphavirus expression vector
01/24/2007EP0758383B1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
01/24/2007CN1902352A Allergen suppressor, allergen-suppression processed fiber and method of producing the same
01/24/2007CN1902227A TIM-3 ligands and methods thereof
01/24/2007CN1902176A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
01/24/2007CN1901933A Methods of stimulating innate immunity using cationic peptides
01/24/2007CN1901912A Preparation of pharmaceutical salts of [1, 4] - bipiperidine
01/24/2007CN1900303A Process for preparing plant immune globulin and its use
01/24/2007CN1900299A Process for preparing novel fungus extracellular amylose with anti-tumor and immunity regulating activity
01/24/2007CN1900279A Polynucleotide for inducing apoptosis and its coded polypeptide and use
01/24/2007CN1900117A Humanized CTLA-4 single chain antibody and human perforin path formed peptide P34 recombinant immunotoxin
01/24/2007CN1900082A Medicinal compound for resisting platelet activating factor
01/24/2007CN1900081A Water soluble artemisine derivative and its preparing method, medicinal composition and use
01/24/2007CN1899603A Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
01/24/2007CN1899554A Tibetan tonic for improving immunity and its preparing method
01/24/2007CN1899447A Deer kidney wine and its preparing method
01/24/2007CN1899438A Miao medicine powder for curing eczema and rubella
01/24/2007CN1899363A Chinese medicine composition for increasing immunity and its preparing method
01/24/2007CN1899362A Quality control method for shenqi injection strengthening body resistance
01/24/2007CN1899361A Zhenqi medicinal composition and its preparation
01/24/2007CN1899322A Chinese medicine preparation with organism immunity increasing function
01/24/2007CN1899320A Method for processing lucid ganoderma spore oil preparations enriched with terpenes
01/24/2007CN1899281A Use of chlorogenic acid in preparing medicine for improving immunity function
01/24/2007CN1899106A Gugan synthetic substance and its preparing method and use
01/24/2007CN1296477C Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method
01/24/2007CN1296380C Pharmaceutical compound
01/24/2007CN1296378C CpG-N ODN gene sequence with high immunological activity CpG-S ODN and antagonism CpG-N ODN and use thereof
01/24/2007CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors
01/24/2007CN1296095C Improved mycoplasma hyopneumoniae bacterin vaccine
01/24/2007CN1296059C Mackefulan immune liquid
01/24/2007CN1296051C New use of dextran sulfate
01/24/2007CN1296039C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
01/23/2007US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
01/23/2007US7166721 Preparation of 1H-imidazo[4,5-C] quinolin 4-amines via novel 1H-imidazo[4,5-c] quinolin 4-cyano and 1H-imidazo[4,5-c] quinolin 4-carboxamide intermediates
01/23/2007US7166708 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide
01/23/2007US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases
01/23/2007US7166694 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
01/23/2007US7166640 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
01/23/2007US7166639 Blocking activation of transcription factor; aminothiophene compound; tissue repair; antiarthritic agents; inflammatory bowel disorders; antihistamines;; osteoporosis; skin disorders; autoimmune diseases
01/23/2007US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
01/23/2007US7166623 Pain and inflammation
01/23/2007US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES
01/23/2007US7166605 Prophylaxis; endothelial diseases, oxidative stress, cardiovascular, inflammatory, cardiovascular, ocular, autoimmune diseases, neurological disorders and cancer, hypercholesterolemia and hyperlipidemia